Tatjana I. Cornu

Hugstetter Str. 55
Freiburg, BW 79106, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Accelerating Translation of NK Cell Therapies to the Clinic: A European Perspective.

Accelerating Translation of NK Cell Therapies to the Clinic: A European Perspective.

Journal: Human gene therapy
Published: August 03, 2026

CD117 epitope-shielded hematopoietic stem cell transplantation with toxin-free conditioning and in vivo selection ameliorates a β-thalassemia model.

CD117 epitope-shielded hematopoietic stem cell transplantation with toxin-free conditioning and in vivo selection ameliorates a β-thalassemia model.

Journal: bioRxiv : the preprint server for biology
Published: July 17, 2026

LRBA regulates actin cytoskeleton dynamics through NMIIA during B cell immune responses.

LRBA regulates actin cytoskeleton dynamics through NMIIA during B cell immune responses.

Journal: EMBO reports
Published: October 22, 2025

Genotoxicity profiling reveals distinct platform-and cell type-specific effects in therapeutic gene editing for genetic hyperinflammation.

Genotoxicity profiling reveals distinct platform-and cell type-specific effects in therapeutic gene editing for genetic hyperinflammation.

Journal: Cell stem cell
Published: August 19, 2025

Lipid nanoparticle-based non-viral in situ gene editing of congenital ichthyosis-causing mutations in human skin models.

Lipid nanoparticle-based non-viral in situ gene editing of congenital ichthyosis-causing mutations in human skin models.

Journal: Cell stem cell
Published: April 03, 2025

Correction: Patients and mice with deficiency in the SNARE protein SYNTAXIN-11 have a secondary B cell defect.

Correction: Patients and mice with deficiency in the SNARE protein SYNTAXIN-11 have a secondary B cell defect.

Journal: The Journal of experimental medicine
Published: May 21, 2024

CRISPR-Cas12a for Highly Efficient and Marker-Free Targeted Integration in Human Pluripotent Stem Cells.

CRISPR-Cas12a for Highly Efficient and Marker-Free Targeted Integration in Human Pluripotent Stem Cells.

Journal: International journal of molecular sciences
Published: December 10, 2023

Safe and effective liver-directed AAV-mediated homology-independent targeted integration in mouse models of inherited diseases.

Safe and effective liver-directed AAV-mediated homology-independent targeted integration in mouse models of inherited diseases.

Journal: Cell reports. Medicine
Published: October 04, 2023

Cell-Based Models of 'Cytokine Release Syndrome' Endorse CD40L and Granulocyte-Macrophage Colony-Stimulating Factor Knockout in Chimeric Antigen Receptor T Cells as Mitigation Strategy.

Cell-Based Models of 'Cytokine Release Syndrome' Endorse CD40L and Granulocyte-Macrophage Colony-Stimulating Factor Knockout in Chimeric Antigen Receptor T Cells as Mitigation Strategy.

Journal: Cells
Published: September 22, 2023

On- and off-target effects of paired CRISPR-Cas nickase in primary human cells.

On- and off-target effects of paired CRISPR-Cas nickase in primary human cells.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 30, 2023

Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy.

Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy.

Journal: The Journal of experimental medicine
Published: July 17, 2023

Gene editing of hematopoietic stem cells restores T-cell response in familial hemophagocytic lymphohistiocytosis.

Gene editing of hematopoietic stem cells restores T-cell response in familial hemophagocytic lymphohistiocytosis.

Journal: The Journal of allergy and clinical immunology
Published: May 07, 2023
Showing 1-12 of 29

Last Updated: 09/26/2026